- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01778270
Not Invasive Monitoring of Pleural Drainage
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
25 patients > 18 years old with pleura effusion will be examined with regard to the feasibility of non invasive sensor measurements corresponding to the course of thorax impedance and respiration parameters during body fluids loss before and after pleural drainage. The measured data will be compared to standard routine reference measurements (heart rate, medication, brain natriuretic peptide (BNP), heart minute volume). Additionally heart sound analysis via electronic stethoscope will be compared to standard methods.
Also 25 healthy controls will undergo the same measurements to receive standard values.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Rhine Westfalia
-
Aachen, North Rhine Westfalia, Germany, 52074
- Univeristy Hospital Aachen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients with pleural effusion undergoing pleural drainage
- male and female patients aged at least 18 years
Exclusion Criteria:
- pregnancy or breast feeding
- implanted pacemaker / Cardiac Resynchronization Therapy (CRT) / Implanted Cardioverter Defibrillator (ICD) except Medtronic Device "OptiVol".
- patients not being able to consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: non invasive sensor pleural drainage
feasibility data will be collected with thorax impedance measurements via body bioimpedance sensor in Ohm before and after pleura drainage, via impedance cardiography stroke volume and cardiac output will be calculated and also respiratory parameters determined via capnograph as carbon dioxide (CO2) in %/ml exhaled volume before and after pleura drainage.
Additionally heart sound analysis via electronic stethoscope will be compared to standard methods.
|
|
Other: non invasive sensor healthy control
the same measurements as in arm 1: feasibility data will be collected with thorax impedance measurements via body bioimpedance sensor before and after pleura drainage in Ohm, via impedance cardiography stroke volume and cardiac output will be calculated and also respiratory parameters determined via capnograph as carbon dioxide (CO2) in %/ml exhaled volume once in 25 healthy controls. Additionally heart sound analysis via electronic stethoscope will be compared to standard methods. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of thorax impedance (Ohm)
Time Frame: once during hospital stay at baseline time 0 before pleura drainage and after pleura drainage at time 1 hour.
|
non invasive bioimpedance measurements to determine feasibility of body fluid loss before and after pleura drainage in 25 patients > 18 years old; also 25 healthy controls are measured to receive standard values
|
once during hospital stay at baseline time 0 before pleura drainage and after pleura drainage at time 1 hour.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of Cardiac output ( l/min) via impedance cardiography
Time Frame: once during hospital stay at baseline time 0 before pleura drainage and after pleura drainage at time 1 hour
|
non invasive bioimpedance measurements to determine feasibility of impedance cardiography before and after pleura drainage; also 25 healthy controls are measured to receive standard values
|
once during hospital stay at baseline time 0 before pleura drainage and after pleura drainage at time 1 hour
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of respiratory parameter CO2 in %/ml exhaled air
Time Frame: once during hospital stay at baseline time 0 before pleura drainage and after pleura drainage at time 1 hour
|
respiratory parameters as CO2 in %/ml exhaled volume will be determined via capnograph
|
once during hospital stay at baseline time 0 before pleura drainage and after pleura drainage at time 1 hour
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Nikolaus Marx, MD, Medical Clinic I, University Hospital Aachen
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10-078
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pleural Effusion
-
Naestved HospitalTerminatedMalignant Pleural Effusion | Exudative Pleural EffusionDenmark
-
Oregon Health and Science UniversityThe Gerber FoundationCompletedChylous Pleural Effusion Following Cardiothoracic SurgeryUnited States
-
Sheng HuWuhan Binhui Biotechnology Co., Ltd.RecruitingMalignant Pleural Effusion | Malignant Peritoneal EffusionChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPleural NeoplasmUnited States
-
Clover Biopharmaceuticals AUS Pty LtdCompletedMalignant Pleural EffusionsAustralia
-
JemincareZhejiang Hangyu Pharmaceutical Co., LtdRecruitingMalignant Pleural EffusionChina
-
National University of Ireland, Galway, IrelandRecruitingMalignant Pleural EffusionIreland
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Not yet recruiting
-
Washington University School of MedicineMerit Medical Systems, Inc.CompletedMalignant Pleural EffusionUnited States
-
Duke UniversityTerminated
Clinical Trials on Body Bioimpedance Sensor
-
Mode Sensors ASOslo University HospitalCompletedEdema | Fluid and Electrolyte Imbalance | OverhydrationNorway
-
Mode Sensors ASRecruiting
-
Obafemi Awolowo University Teaching HospitalMemorial Sloan Kettering Cancer Center; Lagos State University; Federal Medical... and other collaboratorsRecruitingBreast Cancer | Colorectal CancerNigeria
-
Peking University First HospitalFresenius Medical Care (Shanghai) Co., LtdCompletedEnd Stage Renal DiseaseChina
-
University of HertfordshireEast and North Hertfordshire NHS TrustRecruitingAcute Kidney InjuryUnited Kingdom
-
ReThink MedicalNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedHeart Failure | Chronic Kidney DiseasesUnited States
-
Mode Sensors ASOslo University HospitalRecruitingEdema | Kidney Failure | OverhydrationNorway
-
RWTH Aachen UniversityMedical Information Technology (MedIT), RWTH Aachen UniversityTerminated
-
University of ArizonaCompletedParkinson's Disease
-
Allan KemberGrand Challenges Canada; Korle-Bu Teaching Hospital, Accra, Ghana; Innovative... and other collaboratorsCompletedSleep | Pregnancy | Fetal Growth Retardation | Infant, Very Low Birth Weight | Stillbirth | Infant, Small for Gestational Age | Fetal Hypoxia | Infant, Low Birth WeightGhana